Search for: "Battle v. Merck "
Results 41 - 60
of 94
Sorted by Relevance
|
Sort by Date
27 Oct 2011, 11:06 pm
The delays were explained by reference to litigation between Morrissey and his former manager, Merck Mercuriadis, with whom the singer had fallen out in early 2008. [read post]
22 Dec 2014, 3:41 am
******************************PREVIOUSLY, ON NEVER TOO LATENever too late 24 [week ending Sunday 14 December] -- ** INTA’s When Trademarks Overlap With Other IP Rights Special ** | Scottish Law Society misinforms about UPC in Scotland | EPO Enlarged BoA Members’ letter against against President Battistelli’s BoA Member’s house ban | German lititgator writes German delegate to EPO AC | EU Judges join the chorus of condemnation against President Battistelli… [read post]
7 Dec 2014, 3:29 pm
The second is The Copyright Wars: Three Centuries of Trans-Atlantic Battle, written by Peter Baldwin (University of California), which is the first major trans-Atlantic history of copyright from its origins to today. [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
25 Jan 2010, 8:07 pm
” In the context of Appellant’s specification and claims (which are part of the specification, see Merck & Co., Inc. v. [read post]
31 Aug 2010, 10:01 pm
(FDA Law Blog) US: District Court N D Illinois construes claims re method of treating kidney disease: Bone Care v Pentech Pharma (Chicago IP Litigation Blog) Products Angiomax (Bivalirudin) – US: Medicines Company files patent infringement complaint against Hospira in response to Para IV challenge (Patent Docs) Aranesp (Darbepoetin) – EU: ECJ to rule on Aranesp Thursday 2 Sept: Case C-66/09 Kirin Amgen (The SPC Blog) Baraclude (Entecavir) – India: Natco and Zydus Cadila… [read post]
29 Jan 2018, 2:57 am
PREVIOUSLY ON NEVER TOO LATENever too Late 178 [week ending 14 January] A Merck-y appeal is remitted to the High Court | Into fashion law? [read post]
12 Feb 2018, 6:27 am
".Never Too Late 178 [week ending 14 January] A Merck-y appeal is remitted to the High Court | Into fashion law? [read post]
27 Jun 2012, 5:00 am
Judge Fallon found more useful authority in Rivera v. [read post]
25 May 2011, 11:46 pm
Therasense, now Abbott, got into a patent battle involving 5,820,551 and similar patents claiming "disposable blood glucose test strips for diabetes management. [read post]
16 Feb 2018, 12:45 am
Complete the look: Ralph Lauren Polo sweaterKat friend Just Wang analyses another Singaporean opposition trade mark case, in which passing off was relied on as the single (and successful) ground of opposition: When passing off is enough to successfully oppose a trade mark.In the conclusion of another trade mark battle, Mr Justice Arnold has handed down his decision in Sky v Skykick [2018] EWHC 155: BREAKING: Sky's the limit for CJEU references in Sky v SkyKick… [read post]
15 Dec 2014, 7:25 am
There are some rules to build up a decent discussion though, Jeremy recalls. * The Battle of Trumpton: parody, or protection of kippers? [read post]
21 Dec 2017, 7:09 am
This work will encompass multiple research projects with the current proposals looking at: the role of price differentials, sector specific impacts and enforcement impacts.BREAKING: CJEU holds that SPCs cannot be obtained on the basis of an "end of procedure notice" pursuant to Article 3(b) SPC RegulationMr Justice Arnold referred two questions to the CJEU on the SPC Regulation in Merck Sharp & Dohme v Comptroller-General of Patents [2016] EWHC… [read post]
6 Jan 2017, 2:01 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in… [read post]
16 Jun 2010, 3:02 pm
(Patent Docs) Cubicin (Daptomycin) – US: Cubist Pharmaceuticals to oppose Teva’s attempt to add inequitable conduct defense in patent infringement action (SmartBrief) Dorzolamide/Timolol – Netherlands: Preliminary injunction judge rules UK invalidity decision not sufficient to rule non-negligible chance that (Dutch part of) patent will be invalidated in proceedings on the merits: Merck Sharp & Dohme v. [read post]
27 Mar 2012, 12:58 pm
Merck & Co., 949 A.2d 223, 272 (N.J. [read post]
2 Apr 2013, 10:33 am
The generic v. innovator battle has moved on to anti-diabetic drugs, with Glenmark has launched a cheaper generic version of pharma multinational Merck’s blockbuster anti-diabetes drug Januvia (Sitagliptin phosphate), as reported by Madhulika Vishwanathan here. [read post]
11 Jul 2007, 7:01 am
Johnson & Johnson & Merck Consumer Pharmaceuticals, Co., 129 F. [read post]
25 Jan 2017, 10:48 pm
Andrew considered that Regeneron v Kymab [2016] EWHC 87 (Pat) represented the most technically difficult decision of the year, although he noted that Electromagnetic Geoservices v PGS would have run it pretty close had the case not settled. [read post]
5 Jul 2020, 5:43 am
In 1920, the Spanish flu was raging its final battle against the world. [read post]
